BioSpace News Archive

Drug Development

Clinical Catch-Up: NIH’s COVID-19 Trial and All About ASCO

It was a busy, busy week for clinical trial news and updates, largely driven by the annual ASCO meeting taking place June 3-7 in Chicago.

June 3, 2022
·
13 min read
·
Mark Terry
Drug Development

BMS Picks up High Potential NSCLC Drug in $4.1B Turning Point Acquisition

Bristol Myers Squibb announced Friday that it is acquiring San Diego-based Turning Point Therapeutics in a deal totaling about $4.1 billion.

June 3, 2022
·
3 min read
·
Mark Terry
Policy

Study: Paxlovid More Beneficial for Older Adults, White House Update on Kids’ Vaccines

Pfizer’s Paxlovid shows benefits for vaccinated and unvaccinated patients for COVID-19, ages 65 and up while the White House indicates children under five could receive COVID vaccines by June 21.

June 3, 2022
·
2 min read
·
Vanessa Doctor, RN
BioCapital

FDA Expresses Concern Over Myocarditis Ahead of Novavax Adcom

The FDA has expressed worries over four cases of heart inflammation, or myocarditis, that were observed in pivotal clinical trials of Novavax’s COVID-19 vaccine.

June 3, 2022
·
3 min read
·
Mark Terry
Drug Development

Novo Scores Phase III Insulin Icodec Win, Potentially Strengthening Market Position

The results showed that insulin icodec is as non-inferior to Sanofi’s insulin glargine, Lantus, potentially bringing another major competitor into the insulin space.

June 3, 2022
·
3 min read
·
Hannah Chudleigh
Lone Star Bio

Aeglea Stumbles in First BLA Attempt as FDA Issues RTF

The FDA requested more data on effectiveness, particularly evidence that shows plasma arginine and metabolic reduction can predict clinical benefit in patients living with ARG1-D.

June 3, 2022
·
2 min read
·
Vanessa Doctor, RN
Healthcare Informatics Market to Reach Valuation US$ 100 Billion by 2030

According to the report, the healthcare informatics market size was valued at US$ 31 Bn in 2020 and is expected to reach US$ 100 billion by 2030, expanding growth at a noteworthy CAGR of 12.1% from 2021 to 2030.

June 3, 2022
·
11 min read
Ambulatory Cardiac Monitoring Devices Market Size, Growth, Trends, Forecast 2021 to 2030

According to Vision Research Reports, the ambulatory cardiac monitoring devices market value reached at US$ 13.4 billion in 2020 and projected to surpass around US$ 28.7 billion by 2030.

June 3, 2022
·
4 min read
In Vitro Fertilization Test Market Size, Growth, Trends, Forecast 2021-2030

The global in vitro fertilization test market size is expected to hit around US$ 2.8 billion by 2030 and is expected to grow at a noteworthy CAGR of 6.1% from 2020 to 2030.

June 3, 2022
·
6 min read
Laparoscopy Devices Market Size to Hit US$ 16.3 Billion by 2030

The global laparoscopy devices market size is expected to hit around US$ 16.3 billion by 2030 from US$ 8.6 Bn in 2020 with a CAGR of 6.4% from 2021 to 2030.

June 3, 2022
·
8 min read